Siste forsøk

EudraCT Number: 2019-003370-35

Sponsor Protocol Number: MCT8-2019-2

Start Date:

Sponsor Name: Rare Thyroid Therapeutics International AB

Full Title: Tiratricol treatment of children with Monocarboxylate Transporter 8 deficiency: Triac Trial II

Medical condition: Monocarboxylate Transporter 8 (MCT8) deficiency

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Under 18

Gender: Male

Trial protocol: FR (Completed) GB (GB - no longer in EU/EEA) DE (Ongoing) CZ (Ongoing) NL (Ongoing) IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2021-000122-10

Sponsor Protocol Number: NS-065/NCNP-01-302

Start Date:

Sponsor Name: NS Pharma, Inc.

Full Title: A Phase 3, Multi-center, Open-label Extension Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys with Duchenne Muscular Dystrophy (DMD)

Medical condition: Duchenne Muscular Dystrophy (DMD)

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10013801	Duchenne muscular dystrophy	PT

Population Age: Children, Under 18

Gender: Male

Trial protocol: NL (Ongoing) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2017-004187-35

Sponsor Protocol Number: FACE-01

Start Date:

Sponsor Name: Falun Hospital

Full Title: The FACE (Facial nerve palsy And Cortisone Evaluation) study in children: a randomised double-blind, placebo-controlled, multicenter trial.

Medical condition: Facial Nerve Palsy (Bells Palsy)

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004852	10077335	Facial nerve paresis	LLT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: SE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-004691-37

Sponsor Protocol Number:

Start Date:

Sponsor Name: St Vincents University Hospital

Full Title: Etanercept in Psoriasis and Psoriatic Arthritis: a single center, open-label study in 15 patients.

Medical condition: Psoriasis and Psoriatic Arthritis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-001898-32

Sponsor Protocol Number: V87_30

Start Date:

Sponsor Name: Seqirus UK Limited

Full Title: A Phase 2, Randomized, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Several Doses of Antigen and MF59 Adjuvant Content in a Monovalent H5N1 Pandemic Influenza Vacc...

Medical condition: Prophylaxis for Influenza virus

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10021881 - Infections and infestations	10022000	Influenza	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: EE (Ongoing) Outside EU/EEA

Trial results: (No results available)

Siste forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner